Başhekim Yardımcısı Uzm. Dr. Ayça Nazlı BULUT
14 Nisan 2022


888.jpg

Uzm. Dr. Ayça Nazlı BULUT
 BAŞHEKİM YARDIMCISI

Özgeçmiş ve Eserler Listesi

Adı Soyadı     : Ayça Nazlı BULUT

Branşı            :Kadın Hastalıkları ve Doğum

Ünvanı           : Uzman Doktor

Öğrenim Durumu     :

Derece

Bölüm/Program

Üniversite

Yıl

Lisans

Tıp Fakültesi

Erciyes Üniversitesi

1999-2007

Tıpta Uzmanlık

Kadın Hastalıkları ve Doğum

Erciyes Üniversitesi

2011-2015

 

Tıpta Uzmanlık Tezi Başlığı: Ovaryan hiperstimülasyon sendromu riski bulunan kadınlarda GnRHa trigger ile ovulasyon tetiklemesi ve 1500 IU hCG ile luteal destek protokolü ile OHSS oranı ve gebelik başarısının değerlendirilmesi

Tez Danışmanı                      : Prof. Dr. Yılmaz Şahin

Görevler:

Görev Ünvanı

Görev Yeri

Yıl

Dr. Arş. Gör.

Erciyes Üniversitesi-Tıp Fakültesi-Acil Tıp Anabilim Dalı

2007

Pratisyen Hekim

Çorum Sungurlu Devlet Hastanesi

2007-2008

Pratisyen Hekim

Kayseri 112 Acil Sağlık Hizmetleri

2008-2009

Pratisyen Hekim

Kayseri Eğitim ve Araştırma Hastanesi Adli Tıp Birimi

2009-2011

Dr. Arş. Gör.

Erciyes Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı

2011-2015

Uzman Doktor

Siirt Devlet Hastanesi

2015-2016

Uzman Doktor

Kayseri Eğitim ve Araştırma Hastanesi

2016-2018

Research Fellow

Prof.Dr. Ali Ayhan,

Başkent Üniversitesi, Jinekolojik Onkoloji Kliniği

2018 (6 ay)

Uzman Doktor

Kayseri Şehir Eğitim ve Araştırma Hastanesi

2018- 2021

Başhekim Yardımcısı

T.C. Sağlık Bakanlığı Buca Seyfi Demirsoy Eğitim ve Araştırma Hastanesi

2021-Halen

 

ESERLER

A. Uluslararası Hakemli DergilerdeYayınlanan Eserleri

A.1      Dolanbay M, Kutuk MS, Uludag S, Bulut AN, Ozgun MT, Ozcelik B, Serin IS. Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens. Ginekol Pol. 2015;86(10):753-758.  

A.2. Bulut AN, Uludag S, Aygen E, Sahin Y. Ovarian hyperstimulation syndrome ratio and in vitro fertilization success with gonadotrphine releasing hormone trigger and 1500 IU human chorionic gonadotrophine for luteal support. J Gynecol Reprod Med. 2018;2(1):1-7.

A.3Ceyhan V, Bulut AN, Uludag S, Aygen E, Sahin Y. The investigation effects of different luteal support protocols on the patients who applied ovulation induction with gonadotropines and intrauterin insemination.J Reprod Med Gynecol Obstet. 2019;4(1):017

A.4   Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease? Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:209-214.

A.5   Akilli H, Tohma YA, Bulut AN, Karakas LA, Haberal AN, Kuscu UE, Ayhan A. Comparison of noadjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors. Int J Gynaecol Obstet. 2020;149(3):298-302.

A.6     Bulut AN, Ceyhan V. Evaluation of the labour process with serial transperineal ultrasonography and prediction of the type of birth. J Perinat Med. 2020;49(1):36-42.

A.7    Toprak E, Bulut AN. The effect of mask use on maternal oxygen saturation in term pregnancies during the COVID-19 process. J Perinat Med. 2020;49(2):148-152.

A.8    Aydin E, Tanacan A, Bulut AN. A cut-offvalue of epicardial fat thickness for the prediction of large for gestational age foetuses. J Obstet Gynaecol. 2021 Feb;41(2):224-228.

A.9     Bulut AN, Ceyhan V, Demir MB, Ak M, Dolanbay M. Exercise and outcomes in macrosomic pregnancies. J Matern Fetal Neonatal Med. 2021;34(23):3958–3962

A.10  Bulut AN, Ceyhan V, Cundubey CR, Aydin E.The effect of Betamethasone dosing interval on perinatal outcomes: 12 hours or 24 hours apart. Am J Perinatol.2021 Online first.

A.11   Bulut AN, Cundubey CR, Ceyhan V, Aydin E. Comparison of neonatal outcomes with and without the administration of betamethasone in late preterm births. Int J Gynaecol Obstet. 2021 Online first.

 

B. Ulusal Hakemli Dergilerde Yayınlanan Eserleri

B.1    Dolanbay M, Kütük MS, Uludağ S, Özgün MT, Bulut AN, Ökten T. An unusualcase: Pruritic vulvar syringoma. GynecolObstetReprod Med. 2014;20(2):101-102.  

B.2     Aydin E, Bulut AN. Evaluation of the relationship between placental thickness and obstetric doppler parameters during the second trimester. GynecolObstetReprod Med. 2020;26(1):17-20.

B.3   Bulut AN, Ceyhan V. Caesarean indications and rates in a tertiary center. Erciyes Med J. 2022;44(1):39-43

B.4   Bulut AN, Ceyhan V, Demir MB, Ak M, Dolanbay M. Can macrosomic fetuses be delivered at 38 weeks of gestation? Kırıkkale Tıp Dergisi 2021;23(3):422-28

C. Uluslararası Toplantılarda Sunulan Sözlü Bildiriler

C.1 OP-93: Bulut AN, H. Akilli, N.Haberal, A.Haberal, A.Ayhan. NACT versus   Radical Surgery in 1b2 bulky tumors of cervical cancer.1st International, 16th National Turkish Gynecological Oncology Congress 2018.

 C.2 OP-043: Bulut AN. Comparıson of perioperative outcomes of hysterectomy types: Clinical experience of Kayseri City Hospital. IMCIDU 2019 International Medical Congress of Izmir Democracy University.

C.3   OP-238: Bulut AN. Maternal obezite ve gebeliksonuçları. 6. Uluslararası KadınÇocukSağlığıveEğitimiKongresi 2020.

C.4   OP-0055: Bulut AN. Stillbirth During Term Pregnancy and Its Causes. IMCIDU 2020 International Medical Congress of Izmir Democracy University.

C.5 Bulut AN. Sezaryen sonrası vajinal doğum ve sonuçları: Tek merkez deneyimi 7. Uluslararası Kadın Çocuk SağlığıveEğitimi Kongresi 2021

D. Ulusal Toplantılarda Sunulan Poster Bildiriler

 

D.1P05 .15 MS Kutuk, SB Gorkem, C Batukan, Bulut AN, M Basbug. Massive fetal subdural hemorrhage presented with elevated middle cerebral artery flow velocity and reverse end‐diastolic flow. Ultrasound in Obstetrics & Gynecology 2014;44(1):211

D.2   Dolanbay M, Kütük MS, Basbug M, Bulut AN, Ozgun MT. Comparison of different   methods in sonographic estimation of fetal weight in diabetic pregnant women on insulin therapy. Journal of The Turkish German Gynecological Association. 2016;17:145.

E. Uluslararası Toplantılarda Sunulan Poster Bildiriler

E.1   EP253: Ayhan A, Aslan K, Bulut AN, Akilli H, Oz M, Haberal A, Meydanli MM. Is the revised 2018 FIGO staging system for cervical cancer associated with increased discrimination in prognosis for women previously staged as IB disease? A retrospective, dual-institutional study.International Journal of Gynecological Cancer 2019.

F. Atıflar

Eser no:  A.1

Eser adı:  DolanbayM, Kutuk MS, Uludag S, Bulut AN, Ozgun MT, Ozcelik B, Serin İS. Concurrentendometrialcarcinoma in hysterectomyspecimens in patientswithhistopathologicaldiagnosis of endometrialhyperplasia in curettagespecimens. GinekolPol. 2015;86(10):753-758.

 

Atıf Yapan Eserin Endeks Bilgisi

 

SCI

SCI-E

 

 

SCI, SCI-E

Dışındaki Endeksler,

Uluslararası Kitap

 

Ulusal Hakemli Dergiler,

Ulusal Kitap

 

Diğer

(Tez, Bildiri, Ders...vs)

 

Toplam Atıf Sayısı

 

6

 

6

 

1

 

0

 

13

 

  1. Nayyar S, Khan AA, Nayyar A, Nayyar S. Association of obesitywithendometrialcarcinoma. J. Soc. Obstet. Gynecol Pak. 2018;8(3):181-4.
  2. Raffone A,Travaglino A, Saccone G et al.,DiabetesMellitus Is AssociatedwithOccultCancer in EndometrialHyperplasia. Pathology&OncologyResearch 2019:1-8.
  3. Travaglino A,Raffone A,Saccone G,et al.,Endometrialhyperplasiaandthe risk of coexistentcancer: WHO versus EIN criteria. Histopathology 2019;74:676–687.
  4. Travaglino A, Raffone A,Saccone G, et al.,Significant risk of occultcancer in complexnon‑atypicalendometrialhyperplasia. Archives of GynecologyandObstetrics 2019;300:1147–1154.
  5. CakmakY , Oge T , Uslu E , Comert DK, Tosun OA. Evaluation of concurrentendometrialcancer in patientswithendometrialhyperplasia; 10 yearsexperience as a tertiarycenter. Zeynep Kamil Tıp Bülteni2019;50(4):222-226.
  6. Pramana C, Damayanti L, Latuheru EP, et al.,A Histopathologicalstudy of endometrium inabnormaluterinebleeding: aretrospectivestudy. International Journal of PsychosocialRehabilitation 2020;24(5):1-9.
  7. Doherty MT, Sanni OB, Coleman HG et al.,Concurrentandfuture risk of endometrialcancer in womenwithendometrialhyperplasia: A systematicreviewandmetaanalysis. PlosOne 2020;1-21.
  8. Gromova O, Potapov  V,  Hasachihm D,  Haponova O,  Kukina G. Analysis of thecauses of unsuccessfulhormonaltreatment of non-atypicalendometrialhyperplasia in premenopousalwomen. 2020;24(4):1-5.
  9. Громова О.Л, Потапов В.О, Хасхачих Д.A, Гапонова О.В, Кукіна Г.О. АНАЛІЗ ПРИЧИН НЕЕФЕКТИВНОСТІ ГОРМОНОТЕРАПІЇ ГІПЕРПЛАЗІЇЕНДОМЕТРІЯ БЕЗ АТИПІЇ У ЖІНОК У ПРЕМЕНОПАУЗІ. ВісникВінницькогонаціональногомедичногоуніверситету. 2020;24(4):1-7.
  10. Hui LS, Chin SHM, Goh C, Hui LX, Mathur M, Kuei TLY, Xian FCH. Non-atypicalendometrialhyperplasia: risk factorsforoccultendometrialatypiaandmalignancy in patientsmanagedwithhysterectomy. ObstetGynecolSci. 2021Ahead of print.
  11. Gromova OL. Analysıs of theobjectiveandpreventativetreatmentandeffıcacy of therapeuticapproaches in womenwithnon-atypicalendometrialhyperplasia. J EducHealthSport 2021;10(11):1-16.
  12. Gromova O. L.Long-termresults of non-atypıcalhyperplasıatreatment in premenopausalwomenwithdydrogesteron. Bulletin of problemsbiologyandmedicine 2021;1:159
  13. ГромоваОЛ. Национальныймедицинскийуниверситетимени АА Богомольца, Киев, Украина. ReproductiveHealthEastern Europe 2021;1(11):18-32.

Eser no:    A.4

Eser adı: Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM. Is therevised 2018 FIGO stagingsystemforcervicalcancermoreprognosticthanthe 2009 FIGO stagingsystemforwomenpreviouslystaged as IB disease? Eur J ObstetGynecolReprodBiol. 2019 Sep;240:209-214.

 

Atıf Yapan Eserin Endeks Bilgisi

 

SCI

SCI-E

 

 

SCI, SCI-E

Dışındaki Endeksler,

Uluslararası Kitap

 

Ulusal Hakemli Dergiler,

Ulusal Kitap

 

Diğer

(Tez, Bildiri, Ders...vs)

 

Toplam Atıf Sayısı

 

10

 

1

 

0

 

0

 

11

 

  1. Wang H, Li S-W, Li W, Cai H-B. Elastic net-based identification of a multigenecombination predicting the survival of patients with cervical cancer. MedSciMonit, 2019; 25: 10105-10113
  2. Chen X,Zhao N,Ye Pet al.,Comparison of laparoscopicandopenradicalhysterectomy in cervicalcancerpatientswithtumor size ≤2 cm. Int j gynecolcancer2020;30:564–571.
  3. Guo Q, Zhu J, Wu Y et al.,Validation of theprognosticvalue of variouslymphnodestagingsystemsforcervicalsquamouscellcarcinomafollowingradicalsurgery: a single‑centeranalysis of 3,732 patients. AnnTranslMed 2020;8(7):485-498.
  4. Zyla RE,Gien LT, DanielleVicus D et al.,Theprognostic role of horizontalandcircumferentialtumorextent incervicalcancer: Implicationsforthe 2019 FIGO stagingsystem. GynecologicOncology2020;158:266–272.
  5. Zanagnolo V, Baroni C, Achilarre MT, Aloisi A, Betella I, Bogliolo S, et al.,OncologicOutcomes of RoboticRadicalHysterectomy (RRH) forPatientswithEarly-StageCervicalCancer: Experience at a ReferralCancer CenterAnnSurgOncoldoi: 10.1245/s10434-020-09016-1. Online ahead of print.
  6. Balaya V, Guani B, Magaud L, Bonsang-Kitzis H,Ngô C, Mathevet P, et al.,Validation of the 2018 FIGO ClassificationforCervicalCancer: LymphovascularSpace InvasionShould BeConsidered in IB1 Stage. Cancers 2020;12(12):3554.
  7. Bangsomboon P, Kittisiam T, Chaowawanit W. Survival Rate of CervicalCancerPatientsAccordingtothe 2018 FIGO StagingSystem: A tertiaryhospitalbasedstudy, VajiraHospital, Bangkok TJOG 2020, onlinefirst.
  8. Takahashi M, Sakai K, Iwasa N, Wada M, Hino M,Kurahashi T, Ueno M, Nakagawa H. Validation of the FIGO 2018 stagingsystem of cervicalcancer: Retrospectiveanalysis of FIGO 2009 stage IB1cervical cancerwithtumorunder 2 cm. J. Obstet. Gynaecol. Res. 2021ahead of print.
  9. Tang X, Qiu J, Guo C, Guo J, Hua K. A novelprognosticnomogramutilizingthe 2018 FIGO stagingsystemforcervicalcancer: A largemulticenterstudy. International Journal of Gynecology&Obstetrics 2021;1-25.
  10. Kang T, Liu N, Sun X, Liu M. Efficacy of postoperativeradiotherapycombinedwithtaxol+carboplatinchemotherapyregimens in thetreatmentof high-risk early-stageendometrialcancer. JBUON 2021; 26(2): 561-568.
  11. Wang M, Yuan B, Zhou Z-h, Han W-w. Clinicopathologicalcharacteristicsandprognosticfactors of cervicaladenocarcinoma. SciRep2021;11:7506.

Eser No:B.2

Eser Adı:Aydin E, Bulut AN. Evaluation of the relationship between placental thickness and obstetric doppler parameters during the second trimester. GynecolObstetReprod Med 2020;26(1):17-20.

 

Atıf Yapan Eserin Endeks Bilgisi

 

SCI

SCI-E

 

 

SCI, SCI-E

Dışındaki Endeksler,

Uluslararası Kitap

 

Ulusal Hakemli Dergiler,

Ulusal Kitap

 

Diğer

(Tez, Bildiri, Ders...vs)

 

Toplam Atıf Sayısı

 

0

 

1

 

0

 

0

 

1

 

  1. El-Mashad AL, Mahmoud MA, Mansour AE, et al.,Correlation of Placental Morphology and Umblical Doppler Flow Velocimetry with Fetal Outcome. Benha Journal of Applied Sciences 2021;6(1):135-142.

 

 

G. Ulusal / Uluslararası Hakemli Dergilerde Yapmış Olduğu Hakemlikler

  G.1. 831862:Suriyeli Göçmen ve Türkiyeli Gebelerin Primer Sezaryen Oranlarının Karşılaştırılması. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2020.

G.2. Guillain-Barré syndrome complicating first term pregnancy: a case report and review of literatüre. Obstetricsand Gynaecology Cases–Reviews 2021.

G.3. Intimate partner violence with insertion of Capsicum annuum inside the vagina: a case report.International Journal of Obstetrics and Gynecology 2021-12-30

G.4.  Predictive accuracy of the shock index for severe postpartum hemorrhage in high-income countries: a systematic review and meta-analysis. International Journal of Obstetrics and Gynecology 2021-12-30

 

H. Üyesi Olduğu Dernekler

  1. Türk Jinekoloji ve Obstetri Derneği
  2. Türk Ürojinekoloji ve Pelvik Rekonstrüktif Cerrahi Derneği
  3. Jinekolojik Endoskopi Derneği
  4. Üreme Tıbbı ve Cerrahisi Derneği